Cargando…
Discovery and structural characterization of monkeypox virus methyltransferase VP39 inhibitors reveal similarities to SARS-CoV-2 nsp14 methyltransferase
Monkeypox is a disease with pandemic potential. It is caused by the monkeypox virus (MPXV), a double-stranded DNA virus from the Poxviridae family, that replicates in the cytoplasm and must encode for its own RNA processing machinery including the capping machinery. Here, we present crystal structur...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116469/ https://www.ncbi.nlm.nih.gov/pubmed/37080993 http://dx.doi.org/10.1038/s41467-023-38019-1 |
_version_ | 1785028430584086528 |
---|---|
author | Silhan, Jan Klima, Martin Otava, Tomas Skvara, Petr Chalupska, Dominika Chalupsky, Karel Kozic, Jan Nencka, Radim Boura, Evzen |
author_facet | Silhan, Jan Klima, Martin Otava, Tomas Skvara, Petr Chalupska, Dominika Chalupsky, Karel Kozic, Jan Nencka, Radim Boura, Evzen |
author_sort | Silhan, Jan |
collection | PubMed |
description | Monkeypox is a disease with pandemic potential. It is caused by the monkeypox virus (MPXV), a double-stranded DNA virus from the Poxviridae family, that replicates in the cytoplasm and must encode for its own RNA processing machinery including the capping machinery. Here, we present crystal structures of its 2′-O-RNA methyltransferase (MTase) VP39 in complex with the pan-MTase inhibitor sinefungin and a series of inhibitors that were discovered based on it. A comparison of this 2′-O-RNA MTase with enzymes from unrelated single-stranded RNA viruses (SARS-CoV-2 and Zika) reveals a conserved sinefungin binding mode, implicating that a single inhibitor could be used against unrelated viral families. Indeed, several of our inhibitors such as TO507 also inhibit the coronaviral nsp14 MTase. |
format | Online Article Text |
id | pubmed-10116469 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-101164692023-04-22 Discovery and structural characterization of monkeypox virus methyltransferase VP39 inhibitors reveal similarities to SARS-CoV-2 nsp14 methyltransferase Silhan, Jan Klima, Martin Otava, Tomas Skvara, Petr Chalupska, Dominika Chalupsky, Karel Kozic, Jan Nencka, Radim Boura, Evzen Nat Commun Article Monkeypox is a disease with pandemic potential. It is caused by the monkeypox virus (MPXV), a double-stranded DNA virus from the Poxviridae family, that replicates in the cytoplasm and must encode for its own RNA processing machinery including the capping machinery. Here, we present crystal structures of its 2′-O-RNA methyltransferase (MTase) VP39 in complex with the pan-MTase inhibitor sinefungin and a series of inhibitors that were discovered based on it. A comparison of this 2′-O-RNA MTase with enzymes from unrelated single-stranded RNA viruses (SARS-CoV-2 and Zika) reveals a conserved sinefungin binding mode, implicating that a single inhibitor could be used against unrelated viral families. Indeed, several of our inhibitors such as TO507 also inhibit the coronaviral nsp14 MTase. Nature Publishing Group UK 2023-04-20 /pmc/articles/PMC10116469/ /pubmed/37080993 http://dx.doi.org/10.1038/s41467-023-38019-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Silhan, Jan Klima, Martin Otava, Tomas Skvara, Petr Chalupska, Dominika Chalupsky, Karel Kozic, Jan Nencka, Radim Boura, Evzen Discovery and structural characterization of monkeypox virus methyltransferase VP39 inhibitors reveal similarities to SARS-CoV-2 nsp14 methyltransferase |
title | Discovery and structural characterization of monkeypox virus methyltransferase VP39 inhibitors reveal similarities to SARS-CoV-2 nsp14 methyltransferase |
title_full | Discovery and structural characterization of monkeypox virus methyltransferase VP39 inhibitors reveal similarities to SARS-CoV-2 nsp14 methyltransferase |
title_fullStr | Discovery and structural characterization of monkeypox virus methyltransferase VP39 inhibitors reveal similarities to SARS-CoV-2 nsp14 methyltransferase |
title_full_unstemmed | Discovery and structural characterization of monkeypox virus methyltransferase VP39 inhibitors reveal similarities to SARS-CoV-2 nsp14 methyltransferase |
title_short | Discovery and structural characterization of monkeypox virus methyltransferase VP39 inhibitors reveal similarities to SARS-CoV-2 nsp14 methyltransferase |
title_sort | discovery and structural characterization of monkeypox virus methyltransferase vp39 inhibitors reveal similarities to sars-cov-2 nsp14 methyltransferase |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116469/ https://www.ncbi.nlm.nih.gov/pubmed/37080993 http://dx.doi.org/10.1038/s41467-023-38019-1 |
work_keys_str_mv | AT silhanjan discoveryandstructuralcharacterizationofmonkeypoxvirusmethyltransferasevp39inhibitorsrevealsimilaritiestosarscov2nsp14methyltransferase AT klimamartin discoveryandstructuralcharacterizationofmonkeypoxvirusmethyltransferasevp39inhibitorsrevealsimilaritiestosarscov2nsp14methyltransferase AT otavatomas discoveryandstructuralcharacterizationofmonkeypoxvirusmethyltransferasevp39inhibitorsrevealsimilaritiestosarscov2nsp14methyltransferase AT skvarapetr discoveryandstructuralcharacterizationofmonkeypoxvirusmethyltransferasevp39inhibitorsrevealsimilaritiestosarscov2nsp14methyltransferase AT chalupskadominika discoveryandstructuralcharacterizationofmonkeypoxvirusmethyltransferasevp39inhibitorsrevealsimilaritiestosarscov2nsp14methyltransferase AT chalupskykarel discoveryandstructuralcharacterizationofmonkeypoxvirusmethyltransferasevp39inhibitorsrevealsimilaritiestosarscov2nsp14methyltransferase AT kozicjan discoveryandstructuralcharacterizationofmonkeypoxvirusmethyltransferasevp39inhibitorsrevealsimilaritiestosarscov2nsp14methyltransferase AT nenckaradim discoveryandstructuralcharacterizationofmonkeypoxvirusmethyltransferasevp39inhibitorsrevealsimilaritiestosarscov2nsp14methyltransferase AT bouraevzen discoveryandstructuralcharacterizationofmonkeypoxvirusmethyltransferasevp39inhibitorsrevealsimilaritiestosarscov2nsp14methyltransferase |